HERZLIYA, Israel and CALGARY, AB , March 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the " Company " or " Innocan ") is pleased to announce that it has closed its previously announced non-brokered private placement offering of a debenture unit of the Company (the " Debenture Unit ") to its largest shareholder, Tamar Innovest Ltd. (" Tamar Innovest ") for gross proceeds of US $1,000,000... Read More